Table 6.
Multivariate analysis of treatment-related factors for overall survival (OS)
| Factor | Hazard ratio | 95 % CI | p value | |
|---|---|---|---|---|
| PS | 0/1 | 0.11 | 0.002–2.693 | 0.1858 |
| FIGO stage | Stage I, II/III | 5.75 | 0.224–90.468 | 0.2435 |
| Tumor diameter | >5/<5 | 0.25 | 0.009–3.177 | 0.2788 |
| Pre-NAC lymph node metastasis | Positive/negative | 34.88 | 2.969–1152.9 | 0.0031 |
| Tumor response | CR, PR/SD, PD | 30.59 | 3.675–447.9 | 0.0014 |
| Pathological lymph node metastasis | Positive/negative | 1.21 | 0.182–7.932 | 0.836 |
| Postoperative treatment | Yes/no | 6.81 | 0.718–174.323 | 0.0983 |
NAC neoadjuvant chemotherapy